| | | | Lower 2 tertiles
( and <1.1162) | Upper tertiles
(≥1.1162) | value* |
| | Age, y | 30 | 57.5 ± 11.3 | 59.1 ± 6.7 | 0.685 | | Sex, (%) female | 11 | 6 (55) | 5 (45) | 0.425 | | Height, m | 30 | 1.7 ± 0.1 | 1.7 ± 0.1 | 0.589 | | Weight, kg | 30 | 84.5 ± 19.3 | 79.5 ± 17.8 | 0.501 | | Waist, cm | 28 | 107.5 ± 46.2 | 95.9 ± 10.1 | 0.465 | | BMI, (kg/m)2 | 30 | 28.8 ± 5.4 | 27.7 ± 3.3 | 0.567 | | Obesity, (%) | 10 | 8 (80) | 2 (20) | 0.419 | | Abdominal obesity, (%) | 13 | 8 (62) | 5 (38) | 0.505 | | Smoker, (%) | 21 | 12 (57) | 9 (43) | 0.204 | | Coronary artery disease**, (%) | 1 | 1 (100) | 0 (0) | 1.000 | | Hypertension, (%) | 13 | 11 (85) | 2 (15) | 0.119 | | Diabetes, (%) | 4 | 4 (100) | 0 (0) | 0.272 | | Dyslipidemia, (%) | 13 | 8 (62) | 5 (38) | 0.705 | | Statin therapy, (%) | 5 | 3 (60) | 2 (40) | 1.000 | | -Blocker therapy, (%) | 6 | 6 (100) | 0 (0) | 0.074 | | Aspirin therapy, (%) | 5 | 5 (100) | 0 (0) | 0.140 | | ACE-inhibitor therapy, (%) | 4 | 3 (75) | 1 (25) | 1.000 | | ASA risk score > 2, (%) | 28 | 19 (68) | 9 (32) | 0.615 | | Lee Cardiac Risk Index > 2, (%) | 3 | 3 (100) | 0 (0) | 0.107 | | Chemotherapy, (%) | 13 | 7 (54) | 6 (46) | 0.255 | | Radiation therapy, (%) | 10 | 7 (70) | 3 (30) | 0.101 | | PreOp echo/EF, % | 17 | 61.4 ± 3.8 | 62.4 ± 6.9 | 0.709 | | PreOp hemoglobin, mg/dL | 30 | 13.3 ± 1.0 | 13.5 ± 1.4 | 0.705 | | PreOp fasting glucose, mg/dL | 30 | 106.7 ± 28.6 | 95.8 ± 12.0 | 0.260 | | PreOp creatinine, mg/dL | 28 | 1.0 ± 0.3 | 1.0 ± 0.2 | 0.509 | | Length of hospital stay, d | 30 | 11.2 ± 11.7 | 12.6 ± 18.32 | 0.800 | | Length of ICU Stay, d | 30 | 2.4 ± 9.0 | 6.3 ± 19.9 | 0.462 |
|
|
